European microCirculatory Resistance and Absolute Flow Team-The Euro-CRAFT Registry Prospective evaluation of the impact of coronary themodilution on clinical outcomes in chronic coronary syndromes - Euro-CRAFT registry

CoreAalst BV0 个研究点目标入组 100 人开始时间: 待定最近更新: 2024年5月6日

适应症

试验速览

暂无简介。

•Consecutive patients in whom physiological assessment of the microcirculatory
•function including continuous coronary thermodilution has been performed with a
•Pressure-wire X within the context of routine clinical care.

•. Age <18 years
•2. Unable to provide written informed consent (IC)
•3. Unstable hemodynamics
•4. Ongoing chest pain
•5. Previous CABG
•6. Moderate to severe valvular heart disease
•7. Uncontrolled or recurrent ventricular tachycardia.
•8. Active liver disease or hepatic dysfunction, defined as AST or ALT > 3 times
•9. Comorbidity with life expectancy <= 2 years.
•10. Severe renal dysfunction, defined as an eGFR <30 mL/min/1.73 m2.
•11. Subject is currently participating in another investigational drug or
•device clinical study.
•12. Presence of other anatomic or comorbid conditions, or other medical,
•social, or psychological conditions that, in the investigator's opinion, could
•limit the subject's ability to participate in the clinical investigation or to
•comply with follow-up requirements, or impact the scientific soundness of the
•clinical investigation results.

发起方

CoreAalst BV